Sage Journals: Discover world-class research

Open access

Case report

First published 2023-10

Drug extravasation with Enfortumab vedotin

Christopher Ryan Grant, Dimitri de Kouchkovsky, Arash Rezazadeh Kalebasty [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2022-7

Use of enfortumab vedotin in an HIV-positive patient with urothelial carcinoma

Armon Azizi, Roozbeh Houshyar, Nataliya Mar

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2020

Enfortumab Vedotin in urothelial cancer

Marie Alt, Carlos Stecca, Swanee Tobin [...]

Therapeutic Advances in Urology

Retricted access

Case report

First published 2024-8

Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis

Harshit Khosla, Sita Bhatt, Ming-Jin Wang [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2026-3

Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation

Kok Hoe Chan, Putao Cen, Tung Shu [...]

Journal of International Medical Research

Open access

Case report

First published 2024

Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract

Kok Hoe Chan, Tung Shu, Majd Al Shaarani [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Research article

First published 2022

Cost-effectiveness of enfortumab vedotin in previously treated advanced urothelial carcinoma

Qiuji Wu, Yi Qin, Weiting Liao [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

Real-world use of enfortumab vedotin in metastatic urothelial carcinoma: efficacy,safety,and risk stratification

Martina Catalano, Sara Bartoli, Alessia Salfi [...]

Therapeutic Advances in Urology

Retricted access

Review article

First published 2021-6

Enfortumab Vedotin-ejfv: A First-in-Class Anti–Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma

Zachery Halford, Mary Kate Anderson, Matthew D. Clark

Annals of Pharmacotherapy

Open access

Research article

First published 2025-1

Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinoma

Nobutaka Nishimura, Makito Miyake, Norimi Takamatsu [...]

Bladder Cancer

Search results